Correction: Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma (Journal of Hematology & Oncology, (2019), 12, 1, (80), 10.1186/s13045-019-0768-8)

Bhawana George, Suraj Konnath George, Wenyu Shi, Abedul Haque, Ping Shi, Ghazaleh Eskandari, Magnus Axelson, Olle Larsson, Ahmed O. Kaseb, Hesham M. Amin

Research output: Contribution to journalComment/debatepeer-review

Abstract

The original article [1] contains an error in Fig. 4a whereby the figure of one well that belonged to one cell line was used in another cell line. The corrected image can be viewed ahead. (Figure presented.)

Original languageEnglish (US)
Article number61
JournalJournal of Hematology and Oncology
Volume16
Issue number1
DOIs
StatePublished - Dec 2023

ASJC Scopus subject areas

  • Hematology
  • Molecular Biology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma (Journal of Hematology & Oncology, (2019), 12, 1, (80), 10.1186/s13045-019-0768-8)'. Together they form a unique fingerprint.

Cite this